APA
Cassier P. A., Italiano A., Gomez-Roca C. A., Le Tourneau C., Toulmonde M., Cannarile M. A., Ries C., Brillouet A., Müller C., Jegg A., Bröske A., Dembowski M., Bray-French K., Freilinger C., Meneses-Lorente G., Baehner M., Harding R., Ratnayake J., Abiraj K., Gass N., Noh K., Christen R. D., Ukarma L., Bompas E., Delord J., Blay J. & Rüttinger D. (20151027). CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. : The Lancet. Oncology.
Chicago
Cassier Philippe A, Italiano Antoine, Gomez-Roca Carlos A, Le Tourneau Christophe, Toulmonde Maud, Cannarile Michael A, Ries Carola, Brillouet Anne, Müller Claudia, Jegg Anna-Maria, Bröske Ann-Marie, Dembowski Markus, Bray-French Katharine, Freilinger Christine, Meneses-Lorente Georgina, Baehner Monika, Harding Ross, Ratnayake Jayantha, Abiraj Keelara, Gass Nathalie, Noh Karen, Christen Randolph D, Ukarma Lidia, Bompas Emmanuelle, Delord Jean-Pierre, Blay Jean-Yves and Rüttinger Dominik. 20151027. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. : The Lancet. Oncology.
Harvard
Cassier P. A., Italiano A., Gomez-Roca C. A., Le Tourneau C., Toulmonde M., Cannarile M. A., Ries C., Brillouet A., Müller C., Jegg A., Bröske A., Dembowski M., Bray-French K., Freilinger C., Meneses-Lorente G., Baehner M., Harding R., Ratnayake J., Abiraj K., Gass N., Noh K., Christen R. D., Ukarma L., Bompas E., Delord J., Blay J. and Rüttinger D. (20151027). CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. : The Lancet. Oncology.
MLA
Cassier Philippe A, Italiano Antoine, Gomez-Roca Carlos A, Le Tourneau Christophe, Toulmonde Maud, Cannarile Michael A, Ries Carola, Brillouet Anne, Müller Claudia, Jegg Anna-Maria, Bröske Ann-Marie, Dembowski Markus, Bray-French Katharine, Freilinger Christine, Meneses-Lorente Georgina, Baehner Monika, Harding Ross, Ratnayake Jayantha, Abiraj Keelara, Gass Nathalie, Noh Karen, Christen Randolph D, Ukarma Lidia, Bompas Emmanuelle, Delord Jean-Pierre, Blay Jean-Yves and Rüttinger Dominik. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. : The Lancet. Oncology. 20151027.